Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Fast Facts: Hyperlipidemia
'Fast Facts: Hyperlipidemia' is a crisp and accurate summary of lipid disorders, with clear language and illustrations. Directed at a broad range of healthcare professionals, from primary care physicians to specialists, this updated sixth edition addresses the importance of considering lipoprotein particles, not just their lipids. The renowned authors, acknowledging the confusion surrounding the place of statins, carefully unpick clinical trial evidence and discuss guideline recommendations. The result is a clear and logical approach to the management of hyperlipidemia. Table of Contents: • Lipids and lipoprotein particles • Epidemiology and pathophysiology • Familial hypercholesterolemia • Polygenic hypercholesterolemia and combined hyperlipidemia • Hypertriglyceridemia • Familial dysbetalipoproteinemia • Dyslipidemia in insulin resistance, the metabolic syndrome and diabetes mellitus • Secondary hyperlipidemia • Dietary treatment • Drug treatment • When to treat • Biochemical tests
Fast Facts: Hyperlipidemia
'Fast Facts: Hyperlipidemia' provides a crisp and accurate summary of lipid disorders using clear language and illustrations. Directed at a broad range of healthcare professionals, from primary care physicians to specialists, this updated fifth edition addresses the importance of considering lipoprotein particles, not just their lipids. The authors, renowned experts from the UK and USA, interpret clinical trial evidence in the context of pathogenesis and provide practical solutions to the routine problems encountered in the clinical management of hyperlipidemias. Contents: • Lipids and lipoproteins - structure and physiology • Epidemiology and pathophysiology • Familial (monogenic) hypercholesterolemia • Polygenic hypercholesterolemia and combined hyperlipidemia • Hypertriglyceridemia • Familial dysbetalipoproteinemia • Dyslipidemia in insulin resistance, the metabolic syndrome and diabetes mellitus • Secondary hyperlipidemia • Dietary treatment • Drug treatment • When to treat • Biochemical tests • Useful resources
ApoB in Clinical Care
Now, based on the apoB algorithm, that is outlined and illustrated in this book, family physicians as well as cardiologists, endocrinologists and internists will be able to easily and accurately identify and treat these disorders. The apoB dyslipoproteinemias are major common causes of vascular disease. But until now, accurate diagnosis has not been possible. With just total cholesterol, triglycerides and apoB, all the apoB dyslipoproteinemias, with the exception of elevated Lp(a), can be identified using the apoB algorithm. The apoB app, which incorporates this algorithm, is available from both Apple and Android and is free.
Hyperlipidaemia
Fat consumption in western society has increased dramatically throughout the course of the twentieth century. As a consequence, coronary heart disease is now the most common cause of death from middle age onwards in much of the developed world. Yet trials have shown that lipid-lowering drugs can decrease the risk of coronary heart disease and stroke, and increase life expectancy. Using an evidence-based approach this illustrated guide offers practical solutions to the problems encountered by healthcare professionals in the clinical management of hyperlipidaemia.
Hyperlipidemia
None
The Big Fat Surprise
Challenges popular misconceptions about fats and nutrition science, revealing the distorted claims of nutrition studies while arguing that more dietary fat can lead to better health, wellness, and fitness.
Atherosclerosis V
The objective of the program committee of the Fifth International Symposium on Atherosclerosis was to bring together experts in many disciplines to broaden the scope of the attack on this disease and to foster interaction. Our hope was that such interaction would accelerate the eradication of the disease. The symposium achieved that objective and con tinued the tradition of the previous symposia in providing a forum for summaries of recent research developments in the study, treatment and prevention of atherosclerosis. The leading authorities and researchers in this field and in the related areas of interest have presented the newest information, concepts and ideas that have evolved in the p...
Royal Vic
Neville Terry traces the history of the hospital from its founding by Lord Strathcona (Donald Smith) and Lord Mount Stephen (George Stephen) to its present position as a world-renowned health care and research facility. Focusing on the people whose efforts contributed to the Royal Vic's success - physicians, surgeons, nurses, administrators, support staff, researchers, and volunteers - the author recounts their trials and triumphs in bringing about medical, social, and fiscal change in the health care field. The final chapter documents the Royal Vic's achievements in medical research. Health care in Canada has undergone incredible change in the last century, with tremendous advances in medical knowledge and the implementation of government-funded health care. The Royal Vic provides a fascinating overview of this eventful era.
Studies in Inherited Metabolic Disease
captured for the published proceedings. Nevertheless, the two Supplements to this Journal (also available together as a hard-backed book) do, over the years, embrace many of the major aspects of the study of inborn errors of metabolism and can, particularly with the Short Communications section, be used as a way into the literature on specific new topics. We hope that with judicious selection of material these supplements will continue to provide, as did the Society's earlier annual publications, a balanced record of the present state of the subject in all its facets, a record of interest to those working in allied fields as well as to the specialist. R. J. Pollitt G. M. Addison R. A. Harkness The papers listed below were also presented at the meeting. Scripts were not available by the time of publication. 1. Tangier disease and related disorders of apolipoprotein Al. G. Assmann, Munster. 2. Contribution to Ethics Symposium by M. E. Pembrey, London.
Fast Facts
This text provides a crisp and accurate summary of our present knowledge of hyperlipidemia. It reviews recent clinical trials and their findings and appraises current management guidelines with a highly practical focus on determining the best treatment option for each patient. This handbook is perfect for all healthcare professionals looking for an accessible yet authoritative source of information on hyperlipidemia.
